- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
January 17th, 2007
Acrymed hires medical industry veteran
AcryMed, a medical technology company specializing in wound care and infection control, today announced the appointment of David Rardin as the company's vice president of marketing and business development. Rardin, a twenty-one year industry veteran, will focus on the company's SilvaGard® business, which has received increased interest as a breakthrough antimicrobial treatment technology for medical devices.
SilvaGard is a highly effective and safe, broad spectrum, antimicrobial treatment that incorporates nanoparticles of silver to combat bacteria, including methicillin-resistant Staph aureus (MRSA). In December 2005, SilvaGard antimicrobial treatment received its first market clearance for incorporation with indwelling catheters. AcryMed has several other development projects underway that address SilvaGard's incorporation with additional percutaneous and implantable devices and expects to announce new licensing agreements in the coming months. In his role, Rardin will manage these new agreements and help AcryMed generate and manage future business opportunities.
|Related News Press|
Nanoscale Trojan horses treat inflammation May 24th, 2016
Programmable materials find strength in molecular repetition May 23rd, 2016
Revealing the nature of magnetic interactions in manganese oxide: New technique for probing local magnetic interactions confirms 'superexchange' model that explains how the material gets its long-range magnetic order May 25th, 2016
Gigantic ultrafast spin currents: Scientists from TU Wien (Vienna) are proposing a new method for creating extremely strong spin currents. They are essential for spintronics, a technology that could replace today's electronics May 25th, 2016